Lignocaine vs Bupivacaine Infiltration for Postpartum Perineal Pain After Vaginal Delivery With Episiotomy in Primigravidae

Launched by AIN SHAMS UNIVERSITY · Aug 22, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how effective and safe two different medications, lignocaine and bupivacaine, are for relieving pain in new mothers after vaginal delivery with an episiotomy, which is a small surgical cut made to help deliver the baby. The goal is to find out which medication works better for managing postpartum perineal pain, helping mothers feel more comfortable after childbirth.

To participate in this study, you need to be a first-time mother (primigravida) who is delivering a baby vaginally and has had an episiotomy. The trial is looking for women who are in active labor and expecting a single baby. If you have a history of allergies to these medications, are receiving other forms of anesthesia, or have certain medical conditions, you may not be eligible. If you join, you can expect to receive one of the two medications and help researchers understand which one provides better pain relief. The study is currently recruiting participants, so if you're interested, it's a good idea to talk to your healthcare provider for more details.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Primigravidae with the full term undergoing vaginal delivery with episiotomy.
• • Pregnancies and singleton vertex cephalic fetuses.
• • In the active phase of the first stage of labor.
• Exclusion Criteria:
• • Patients with history of drug allergies to study drugs as this will increase the risk of complications.
• • Patients undergoing vaginal delivery under epidural or spinal anesthesia as they will affect post-operative pain and interfere with assessment of efficacy of local infiltration of the study drugs.
• • Evidence of local infection at site of injection as this will interfere with the action of the study drug and will increase the risk of complications.
• • Inability to cooperate as this will affect our assessment.
• • Patient's refusal.
• • Any intraoperative complications that will affect our outcome criteria (bleeding, organ injury) as they will affect patient's vital data and affect our assessment.
• • Neurological comorbidities (chronic pain disorder, chronic systemic disease, neurological disorder, neuropathic pain) as they will need more analgesia.
• • Drug abuse as they will be tolerant to the used analgesics.